As Popular (BPOP) Shares Declined, Shareholder Thomas J Herzfeld Advisors Has Lifted Its Stake; Fernwood Investment Management Stake in Portola Pharmaceuticals Com (PTLA) Decreased as Share Value Rose

January 13, 2018 - By Richard Conner

Fernwood Investment Management Llc decreased its stake in Portola Pharmaceuticals Inc Com (PTLA) by 3.89% based on its latest 2017Q3 regulatory filing with the SEC. Fernwood Investment Management Llc sold 9,300 shares as the company’s stock rose 22.73% with the market. The institutional investor held 229,577 shares of the health care company at the end of 2017Q3, valued at $12.40M, down from 238,877 at the end of the previous reported quarter. Fernwood Investment Management Llc who had been investing in Portola Pharmaceuticals Inc Com for a number of months, seems to be less bullish one the $3.43 billion market cap company. The stock increased 0.55% or $0.29 during the last trading session, reaching $52.62. About 623,664 shares traded. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has risen 51.17% since January 13, 2017 and is uptrending. It has outperformed by 34.47% the S&P500.

Thomas J Herzfeld Advisors Inc increased its stake in Popular Inc (BPOP) by 93.95% based on its latest 2017Q3 regulatory filing with the SEC. Thomas J Herzfeld Advisors Inc bought 29,500 shares as the company’s stock declined 15.91% while stock markets rallied. The institutional investor held 60,900 shares of the finance company at the end of 2017Q3, valued at $2.19 million, up from 31,400 at the end of the previous reported quarter. Thomas J Herzfeld Advisors Inc who had been investing in Popular Inc for a number of months, seems to be bullish on the $3.94 billion market cap company. The stock increased 1.55% or $0.59 during the last trading session, reaching $38.63. About 725,652 shares traded. Popular, Inc. (NASDAQ:BPOP) has risen 26.79% since January 13, 2017 and is uptrending. It has outperformed by 10.09% the S&P500.

Analysts await Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) to report earnings on February, 27. They expect $-1.52 EPS, down 60.00% or $0.57 from last year’s $-0.95 per share. After $-1.41 actual EPS reported by Portola Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 7.80% negative EPS growth.

Since December 15, 2017, it had 0 insider buys, and 1 sale for $563,950 activity.

Investors sentiment increased to 2.16 in Q3 2017. Its up 0.85, from 1.31 in 2017Q2. It improved, as 20 investors sold PTLA shares while 37 reduced holdings. 38 funds opened positions while 85 raised stakes. 56.33 million shares or 15.80% more from 48.64 million shares in 2017Q2 were reported. San Francisco Sentry Inv Grp Inc (Ca) has invested 0% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Cornerstone Management Hldgs Limited Liability Co holds 21,014 shares. 691 are owned by Meeder Asset Management. Federated Invsts Pa invested in 0.01% or 67,616 shares. Fortaleza Asset reported 0.29% stake. Edge Wealth Limited Liability Company holds 75 shares or 0% of its portfolio. Numeric Investors Llc owns 0.07% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 158,300 shares. Pnc Financial Services Group has invested 0% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Strs Ohio owns 207,100 shares. Teacher Retirement Sys Of Texas accumulated 0% or 5,310 shares. Temasek (Private) stated it has 1.54% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Citigroup holds 0% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 60,014 shares. Wells Fargo Mn has invested 0% of its portfolio in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Renaissance Tech Lc has 0.03% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). First Mercantile Co has 7,500 shares for 0.07% of their portfolio.

Among 6 analysts covering Portola Pharmaceuticals (NASDAQ:PTLA), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Portola Pharmaceuticals had 32 analyst reports since August 5, 2015 according to SRatingsIntel. Credit Suisse maintained Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) on Friday, August 19 with “Neutral” rating. As per Thursday, December 28, the company rating was maintained by Oppenheimer. The company was maintained on Thursday, August 10 by Oppenheimer. The stock has “Buy” rating by Morgan Stanley on Monday, June 26. The stock has “Buy” rating by Goldman Sachs on Friday, December 1. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has “Hold” rating given on Thursday, August 10 by Credit Suisse. Goldman Sachs downgraded it to “Neutral” rating and $30 target in Monday, March 28 report. Oppenheimer maintained Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) on Friday, August 4 with “Buy” rating. Cowen & Co maintained it with “Buy” rating and $7000 target in Wednesday, August 9 report. The stock has “Buy” rating by Credit Suisse on Wednesday, September 20.

Among 16 analysts covering Popular Inc (NASDAQ:BPOP), 13 have Buy rating, 1 Sell and 2 Hold. Therefore 81% are positive. Popular Inc had 34 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Popular, Inc. (NASDAQ:BPOP) earned “Buy” rating by Piper Jaffray on Friday, October 6. The firm earned “Sell” rating on Monday, August 24 by Zacks. Compass Point upgraded the stock to “Buy” rating in Friday, November 3 report. The rating was maintained by Piper Jaffray on Wednesday, November 1 with “Buy”. Guggenheim upgraded Popular, Inc. (NASDAQ:BPOP) on Monday, July 27 to “Buy” rating. The stock of Popular, Inc. (NASDAQ:BPOP) has “Buy” rating given on Tuesday, October 31 by BTIG Research. The stock of Popular, Inc. (NASDAQ:BPOP) earned “Buy” rating by Compass Point on Thursday, February 25. The rating was maintained by RBC Capital Markets with “Buy” on Wednesday, June 28. The firm has “Equal-Weight” rating by Morgan Stanley given on Wednesday, December 13. The firm earned “Overweight” rating on Wednesday, November 1 by Barclays Capital.

Investors sentiment increased to 1.58 in 2017 Q3. Its up 0.83, from 0.75 in 2017Q2. It improved, as 22 investors sold BPOP shares while 56 reduced holdings. 42 funds opened positions while 81 raised stakes. 89.00 million shares or 5.87% more from 84.07 million shares in 2017Q2 were reported. Great Lakes Limited Liability Corporation stated it has 0.08% of its portfolio in Popular, Inc. (NASDAQ:BPOP). Convergence Invest Prtnrs Lc stated it has 51,759 shares or 0.26% of all its holdings. Thrivent Fincl For Lutherans accumulated 327,830 shares. Numeric Ltd Liability accumulated 837,535 shares or 0.23% of the stock. Heartland Advsr has 0.02% invested in Popular, Inc. (NASDAQ:BPOP) for 8,805 shares. Diamond Hill Management stated it has 4.13M shares. Hanseatic Mngmt Svcs Incorporated has invested 0.04% in Popular, Inc. (NASDAQ:BPOP). Baystate Wealth Management Limited Liability Corporation invested 0% in Popular, Inc. (NASDAQ:BPOP). Prudential Fincl stated it has 903,755 shares. Secor Advsrs Limited Partnership accumulated 47,309 shares. Sg Americas Limited Liability Corp stated it has 0% of its portfolio in Popular, Inc. (NASDAQ:BPOP). Arrowstreet Capital Partnership holds 7,200 shares or 0% of its portfolio. Qs Ltd Liability invested 0% in Popular, Inc. (NASDAQ:BPOP). First Republic Invest owns 5,553 shares. Pennsylvania-based Nationwide Fund Advsrs has invested 0.01% in Popular, Inc. (NASDAQ:BPOP).

Thomas J Herzfeld Advisors Inc, which manages about $185.74M and $226.85M US Long portfolio, decreased its stake in First Trust Dynamic Europe Equity Income Fund by 30,271 shares to 58,226 shares, valued at $1.12M in 2017Q3, according to the filing. It also reduced its holding in Rmr Real Estate Income Fund by 83,837 shares in the quarter, leaving it with 6,625 shares, and cut its stake in Pioneer Municipal High Income Trust (NYSE:MHI).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts